Cognition in Parkinson's Disease

Defining the problem 1. Introduction N. S. Narayanan and Roger L. Albin 2. The epidemiology of cognitive function in Parkinson's disease Caroline M Tanner and Meredith A. Bock 3. Neuropsychology of Parkinson's disease Steven Anderson and Cole Toovey 4. Cognitive dysfunction and neuropsychiatric aspects of Parkinson's disease Laura Marsh and Gabriela Austgen

Clinical characteristics 5. Cognition in Prodromal Parkinson's disease Inga Liepelt-Scarfone, Anja Ophey and Elke Kalbe 6. Real-life consequences of cognitive dysfunction in Parkinson's disease Ergun Y. Uc and Kevin Kay 7. Cognitive control and Parkinson's disease James F. Cavanagh, Sarah Pirio Richardson and Sephira Ryman 8. Speech dysfunction, cognition, and Parkinson's disease Jeremy Greenlee, Kris Tjaden, Andrea Rohl, Stephanie Gutierrez and Angela C. Roberts Pathophysiology 9. Neuropathology and Cognition in Parkinson's disease David J. Irwin and David Coughlin 10. Genetics of cognitive dysfunction in Parkinson's disease Roy Alcalay and Adina Wise 11. Animal models of action control and cognitive dysfunction in Parkinson's disease Bernard Balleine 12. Neuroimaging approaches to cognition in Parkinson's disease Kathleen L. Poston, Leila Kouhsari and Christina Young

Circuit mechanisms 13. Functional neuroanatomy of cognition in Parkinson's disease Nader Pouratian, Timothy J. Florence, Cody Wolfe and Koorosh Mirpour 14. Role of dopamine and clinical heterogeneity in cognitive dysfunction in Parkinson's disease' Roshan Cools, Jorryt Tichelaar, Rick Helmich, Bas Bloem, Rianne Esselink, Katrijn Smulders and Monique Timmer 15. Cholinergic Systems, Attentional-Motor Integration, and Cognitive Control in Parkinson Disease Roger L. Albin, Martin Sarter, Sygrid van der Zee, Teus van Laar, Cindy Lustig, Martijn Muller and Nicolaas I.L.J Bohnen 16. Cognition and serotonin in Parkinson's disease Philippe Huot, Sebastien Belliveau, Imane Frouni and Cynthia Kwan

Towards therapies 17. Caring for patients with cognitive dysfunction, fluctuations and dementia caused by Parkinson's Disease Georgina Aldridge, Oday Halhouli and Qiang Zhang 18. Neuromodulation of cognition in Parkinson's disease N. S. Narayanan, Rachel Cole, Derrick Okine and Brooke Yeager 19. The way forward for cognition and Parkinson's disease N. S. Narayanan and Roger L. Albin

Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.

• Neurociências
• Fisiológico e neuro-psicologia, biopsicologia

Acetycholine; Acetylcholine; Action control; Alpha-synuclein; Amyloid-ss; Animal models; Anxiety; Apathy; Assessment; Attention; Basal forebrain; Basal ganglia; Brain activation; Cholinergic interneurons; Clinical utility; Cognition; Cognitive control; Cognitive dysfunction; Cognitive fluctuations; Cognitive impairment; Cognitive impairments; Cognitive screening; Cognitive symptoms; Communication; Communication participation; Conclusion; Conversation; Corticostriatal circuits; Decision making; Decision-making capacity; Deep brain stimulation; Delusions; Dementia; Dementia with Lewy bodies; Depression; Diffusion tensor imaging; Dopamine; Dopaminergic medication; Dorsomedial striatum; Driving; Early detection; Epidemiology; Executive dysfunction; Executive function; Frontoparietal; Frontostriatal; Functional connectivity; Functional MRI (fMRI); Gambling; Genetics; Goal-directed action; GWAS; Habits; Hallucinations; Heterogeneity; Impulse control disorder; Impulse control disorders; Lewy Body Dementia; Magnetic resonance imaging (MRI); Major depression; Memory; Mesocortical; Mild cognitive impairment; Movement disorders; Multidisciplinary; Neural network; Neuropathology; Neuropsychological assessment; Neuropsychological evaluation of Parkinson's disease; Non-major depression; Nonmotor symptoms; Noradrenaline; Noradrenergic; Occupation; Orienting; Overdose hypothesis; Parkinson; Parkinson disease; Parkinson's disease; PD dementia; PD mild cognitive impairment; Pedunculopontine nucleus; Polymorphism; Positron emission tomography (PET); Prefrontal cortex; Prodromal; Psychiatric disorder; Psychosis; Quality of life; Reinforcement learning; Resting state fMRI; Serotonin; Side effects; Single photon emission computed tomography (SPECT); Social life; Speech; Speech-language therapy; Spiny projection neurons; Spoken language; Striatum; Task switching; Task-based fMRI; Tau; Transcranial alternating current stimulation; Transcranial direct current stimulation; Transcranial magnetic stimulation; Treatment; Tremor phenotype; Variants; Voice; White matter hyperintensities